Syndax Pharmaceuticals (STU:1T3) Short-Term Capital Lease Obligation : €0.97 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Syndax Pharmaceuticals Short-Term Capital Lease Obligation?

Syndax Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.97 Mil.

Syndax Pharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€0.94 Mil) to Dec. 2023 (€0.96 Mil) and increased from Dec. 2023 (€0.96 Mil) to Mar. 2024 (€0.97 Mil).

Syndax Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€0.32 Mil) to Dec. 2022 (€0.41 Mil) and increased from Dec. 2022 (€0.41 Mil) to Dec. 2023 (€0.96 Mil).

Syndax Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Syndax Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syndax Pharmaceuticals Short-Term Capital Lease Obligation Chart

Syndax Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.43

0.26

0.32

0.41

0.96

Syndax Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.43	0.89	0.94	0.96	0.97

Syndax Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Syndax Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Syndax Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Syndax Pharmaceuticals (STU:1T3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syndax Pharmaceuticals Inc (STU:1T3) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SNDX:USA

Address

35 Gatehouse Drive, Building D, Floor 3, Waltham, MA, USA, 02451

Website

https://www.syndax.com

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Syndax Pharmaceuticals (STU:1T3) Headlines

No Headlines